High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer

Human Reproduction

Volumn 25, Issue 10, 2010, Pages 2543-2550

  Quinn, Gwendolyn P ^a   Vadaparampil, Susan T ^a   Miree, Cheryl A ^a   Lee, Ji Hyun ^a   Zhao, Xiuhua ^a   Friedman, Susan ^b   Yi, Susan ^a   Mayer, James ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Facing Our Risk of Cancer Empowered FORCE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

BRCA; high risk men; men's health; PGD; reproductive decision making

Indexed keywords

NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HEALTH SURVEY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; MORALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARY CANCER; PERCEPTION; PRE IMPLANTATION GENETIC DIAGNOSIS; RELATIVE; RELIGION; RISK ASSESSMENT;

EID: 77956926263     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq207     Document Type: Article

References (37)

1. Baruch S, Kaufman D, Hudson KL. Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics. Fertil Steril 2008; 89:1053-1058.
2. Basille C, Frydman R, Aly AE, Hesters L, Fanchin R, Tachdjian G, Steffann J, LeLorch M, Achour-Frydman N. Preimplantation genetic diagnosis: state of the art. Eur J Obstet Gynecol Reprod Biol 2009;145:9-13.
3. Borkenhagen A, Brahler E, Wisch S, Stobel-Richter Y, Strauss B, Kentenich H. Attitudes of German infertile couples towards preimplantation genetic diagnosis for different uses: a comparison to international studies. Hum Reprod 2007;22:2051-2057.
4. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002;94:1365-1372.
5. Browner CH, Preloran HM. Male partners role in Latinas amniocentesis decisions. J Genet Couns 1999;8:85-108.
6. dAgincourt-Canning L. Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics 2001;15:231-247.
7. Daly MB. The impact of social roles on the experience of men in BRCA1/2 families: implications for counseling. J Genet Couns 2009;18:42-48.
8. Fernández DO, De Vincentiis S, Chillik CF, Brugo-Olmedo SP. Patients opinions regarding preimplantation genetic diagnosis in a Latin American fertility clinic. Fertil Steril 2004;81:463-464.
9. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J et al. Genetic heterogeneity and penetrance analysis of the BRC A1 and BRCA2 genes inbreastcancer families. Am J Hum Genet 1998;62:676-689.
10. Fortuny D, Balmana J, Grana B, Torres A, Cajal TRy, Darder E, Gadea N, Velasco A, Lopez C, Sanz J et al. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum Reprod 2009;24:1000-1006.
11. Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. Med Gen Med 2005;7:60.
12. Goelen G, Teugels E, Bonduelle M, Neyns B, De Greve J. High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects. J Med Genet 1999;36:304-308.
13. Hallowell N, Arden-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M. Guilt, blame and responsibility: mens understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health Illn 2006;28:969-988.
14. Hudson KL. Preimplantation genetic diagnosis: public policy and public attitudes. Fertil Steril 2006;85:1638-1645.
15. Klitzman R, Appelbaum PS, Chung W, Sauer M. Anticipating issues related to increasing preimplantation genetic diagnosis use: a research agenda. Reprod Biomed Online 2008;17:33-42.
16. Lammens C, Bleiker E, Aaronson N, Vriends A, Ausems M, Jansweijer M, Wagner A, Sijmons R, van den Ouweland A, van der Luijt R et al. Attitude towards pre-implantation genetic diagnosis for hereditary cancer. Fam Cancer 2009;8:457-464.
17. Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, Rabinovici J, Potashnik G, Lunenfeld E, Schenker J et al. Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer-a Historical Prospective Cohort of Israeli Women. Breast Cancer Res Treat 2006;100:201-212.
18. Meister U, Finck C, Stobel-Richter Y, Schmutzer G, Brahler E. Knowledge and attitudes towards preimplantation genetic diagnosis in Germany. Hum Reprod 2005;20:231-238.
19. Menon U, Harper J, Sharma A, Fraser L, Burnell M, ElMasry K, Rodeck C, Jacobs I. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007;22:1573-1577.
20. Mohamad HB, Apffelstaedt JP. Counseling for male BRCA mutation carriers: a review. Breast 2008;17:441-450.
21. Offit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S, White M, Sagi M, Bernstein D, Davis JG. Cancer genetic testing and assisted reproduction. J Clin Oncol 2006;24:4775-4782.
22. Ogilvie CM, Braude P, Scriven P. Successful pregnancy outcomes after preimplantation genetic diagnosis (PGD) for carriers of chromosome translocations. Hum Fertil 2001;4:168-171.
23. Ottini L, Masala G, DAmico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003; 63:342-347.
24. Queller J. Pretty is What Changes, New York: Spiegel and Grau, 2008.
25. Quinn G, Vadaparampil S, Wilson C, King L, Choi J, Miree C, Friedman S. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril 2008;91:2361-2368.
26. Rappaport VJ. Prenatal diagnosis and genetic screening-integration into prenatal care. Obstet Gynecol Clin North Am 2008;35:435-458.
27. Robertson JA. Extending preimplantation genetic diagnosis: the ethical debate. Ethical issues in new uses of preimplantation genetic diagnosis. Hum Reprod 2003;18:465-471.
28. Robertson JA. Protecting embryos and burdening women: assisted reproduction in Italy. Hum Reprod 2004;19:1693-1696.
29. Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for Heritable Neoplasia. J Natl Cancer Inst Monogr 2005; 2005:87-90.
30. Smith K, West J, Croyle R, Botkin J. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings test results on psycholgocial distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol Biomarkers Prev 1999;8:385-392.
31. Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008;7:179-186.
32. Strømsvik N, Råheim M, Øyen N, Gjengedal E. Men in the womens world of hereditary breast and ovarian cancer-a systematic review. Fam Cancer 2009;8:221-229.
33. Strømsvik N, Råheim M, Øyen N, Engebretsen L, Gjengedal E. Stigmatization and male identity: Norwegian males experience after identification as BRCA1/2 mutation carriers. J Genet Couns 2010; 19:360-370.
34. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-1408.
35. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999;91:1310-1316.
36. Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001;68:410-419.
37. Vadaparampil ST, Quinn GP, Knapp C, Malo TL, Friedman S. Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer. Genet Med 2009;11:757-765.